Issues
-
Cover Image
Cover Image
ON THE COVER
Journal of Human Immunity (JHI) publishes papers that provide novel insights into the physiology and pathology of human immunity through the study of genetic defects and their phenocopies, including the study of leukocytes and other cells. The journal focuses on human inborn errors of immunity, encompassing conditions as diverse as infection, autoimmunity, autoinflammation, malignancy, and allergy. - PDF Icon PDF LinkEditorial Board
Editorial
Human immunity
Human immunity is often insufficient against infectious agents and sometimes over-reactive to innocuous components of the environment or the human body. Genetic, immunological, and clinical studies of inborn errors of immunity—where responses are either too weak or too strong—offer unprecedented insights into the physiology and pathology of host defense. This is the focus of the Journal of Human Immunity.
Review
Revisiting X-linked agammaglobulinemia
Although the pathogenesis of XLA is well understood, several issues remain open for discussion. We describe several unresolved issues, including non-coding BTK variants, contiguous deletion syndrome, Helicobacter infection, non-infectious neurodegeneration, renal involvement, and malignancies.
Articles
The 2024 update of IUIS phenotypic classification of human inborn errors of immunity
Here, we report the 2024 update of the phenotypic classification by the International Union of Immunological Societies (IUIS) expert committee on inborn errors of immunity (IEI). This phenotypic classification is presented in the form of decision trees when possible, with essential clinical or immunological phenotype entries.
Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee
Here we provide a comprehensive update to the classification of monogenic immune disorders.
Gut dysbiosis patterns in CVID patients with noninfectious complications observed in a germ-free mouse model through fecal microbiota transplantation
Hajjar et al. identify distinct gut microbiome profiles in CVID patients with noninfectious complications and establish a novel germ-free mouse model using fecal microbiota transplant. This model recapitulates human dysbiosis and provides a platform to explore microbiome-driven immune dysregulation in CVID.
Email alerts
Most Read
Advertisement